Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation

被引:13
作者
Gholam Ali Naderi
Seddigheh Asgary
Nizal Sarraf-Zadegan
Hamid Shirvany
机构
[1] Isfahan University of Medical Sciences,Department of Biochemistry, Isfahan Cardiovascular Research Center
[2] Isfahan University of Medical Sciences,Department of Pharmacognosy, Isfahan Cardiovascular Research Center
[3] Isfahan University of Medical Sciences,Department of Cardiology, Isfahan Cardiovascular Research Center
来源
Molecular and Cellular Biochemistry | 2003年 / 246卷
关键词
antioxidant; LDL oxidation; flavonoid; natural product; atherosclerosis;
D O I
暂无
中图分类号
学科分类号
摘要
In vitro studies have demonstrated increased atherogenicity of oxidized low-density lipoprotein (ox-LDL) compared to native LDL. Oxidative modification of LDL alters its structure allowing LDL to be taken up by scavenger receptors on macrophage, endothelial, and smooth muscle cells, leading to the formation of lipid-laden foam cells, the hallmark of early atherosclerotic lesions. The susceptibility of LDL to in vitro oxidation was assessed essentially by the technique described by Esterbauer et al. LDL oxidation were monitored by change in 234-absorbance in the presence and absence of pure flavonoids. Morin, genistein, apigenin and biochanin A, naringin and quercetin were used at different concentration. These flavonoids significantly inhibit in vitro LDL oxidation, genistein, morin and naringin have stronger inhibitory activity against LDL oxidation than biochanin A or apigenin. This study show that flavonoids prevent in vitro LDL oxidation and probably would be important to prevent atherosclerosis.
引用
收藏
页码:193 / 196
页数:3
相关论文
共 58 条
[1]  
Witzum JL(1994)The oxidation hypothesis of atherosclerosis Lancet 344 793-798
[2]  
Witzum JL(1991)Role of oxidized low density lipoprotein in atherogeneis J Clin Invest 88 1785-1792
[3]  
Steinberg D(1987)Plasma levels of anti-oxidant vitamins in relation to ischemic heart disease A J Clin Nutr 45 1368-1377
[4]  
Geg KF(1992)Dietary anti-oxidants and cardiovascular disease Ann NY Acad Sci 669 249-259
[5]  
Brubacher GB(1992)Workshop participants. Anti-oxidants in the prevention of human atherosclerosis Circulation 85 2338-2344
[6]  
Stahelin HB(1995)Effect of J Am Coll Nutr 14 16-52
[7]  
Gaziano JM(1993) supplemention with low dose vitamin E on susceptibility of low density lipoprotein and high density lipoprotein to oxidative modification Lancet 345 1007-1011
[8]  
Manson JE(1995)Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly study Arch Intern Med 155 381-386
[9]  
Buring JE(1992)Flavonoids intake and long-term risk of coronary heart disease and cancer in the seven countries study Lancet 339 1523-1526
[10]  
Hennekens CH(1969)Wine, alcohol, platelets and the French paradox for coronary heart disease Lipids 4 337-344